BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 32617980)

  • 1. Identification of novel genes in testicular cancer microenvironment based on ESTIMATE algorithm-derived immune scores.
    Ke ZB; Wu YP; Huang P; Hou J; Chen YH; Dong RN; Lin F; Wei Y; Xue XY; Ng CF; Xu N
    J Cell Physiol; 2021 Jan; 236(1):706-713. PubMed ID: 32617980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance analysis of GDF3 in testicular cancer based on TCGA and GTEx databases].
    Yan ZC; Liu TH; Yu SB; Zhan YH; Wang ZY; Zhu ZW; Reng YL; Shang XJ; Zhang XP
    Zhonghua Nan Ke Xue; 2023 Dec; 29(12):980-985. PubMed ID: 38639949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics Analysis.
    Wu YP; Lin XD; Chen SH; Ke ZB; Lin F; Chen DN; Xue XY; Wei Y; Zheng QS; Wen YA; Xu N
    Front Genet; 2020; 11():892. PubMed ID: 32922436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
    Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
    J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis.
    Xu N; Ke ZB; Lin XD; Chen YH; Wu YP; Chen Y; Dong RN; Chen SH; Li XD; Wei Y; Zheng QS; Lin YZ; Xue XY
    Cancer Cell Int; 2020; 20():302. PubMed ID: 32675942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer.
    Xu N; Ke ZB; Chen YH; Wu YP; Chen SH; Wei Y; Zheng QS; Huang JB; Li XD; Xue XY
    Front Oncol; 2020; 10():1547. PubMed ID: 32923401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
    Shi B; Qi J
    J Cell Physiol; 2021 Apr; 236(4):2620-2630. PubMed ID: 32853461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
    Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
    Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a TP53-associated immune prognostic model for gastric cancer.
    Nie K; Zheng Z; Wen Y; Shi L; Xu S; Wang X; Zhou Y; Fu B; Li X; Deng Z; Pan J; Jiang X; Jiang K; Yan Y; Zhuang K; Huang W; Liu F; Li P
    Genomics; 2020 Nov; 112(6):4788-4795. PubMed ID: 32858135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies.
    Chen H; Qin Q; Xu Z; Chen T; Yao X; Xu B; Sun X
    J Cell Physiol; 2021 Mar; 236(3):2126-2138. PubMed ID: 32830322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Prolonged Laparoscopic Radical Prostatectomy and the Creation of a Scoring System for the Duration.
    Chen SH; Ke ZB; Wu YP; Chen DN; Yu X; Chen Y; Wei Y; Zheng QS; Xue XY; Xu N
    Cancer Manag Res; 2020; 12():8005-8014. PubMed ID: 32943933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma.
    Liang J; Liu T; Liao J; Zhang L; Zhou M; Xu W; He Y; Cai G; Jin G; Song J; Li G; Liang H; Ding Z; Zhang B
    J Cell Physiol; 2021 Apr; 236(4):3143-3156. PubMed ID: 32996133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.
    Marinelli D; Mazzotta M; Scalera S; Terrenato I; Sperati F; D'Ambrosio L; Pallocca M; Corleone G; Krasniqi E; Pizzuti L; Barba M; Carpano S; Vici P; Filetti M; Giusti R; Vecchione A; Occhipinti M; Gelibter A; Botticelli A; De Nicola F; Ciuffreda L; Goeman F; Gallo E; Visca P; Pescarmona E; Fanciulli M; De Maria R; Marchetti P; Ciliberto G; Maugeri-SaccĂ  M
    Ann Oncol; 2020 Dec; 31(12):1746-1754. PubMed ID: 32866624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic identification of key pathways, hub genes, and microbiota for therapeutic intervention in Helicobacter pylori infection.
    Chen Z; Chen H; Yu L; Xin H; Kong J; Bai Y; Zeng W; Zhang J; Wu Q; Fan H
    J Cell Physiol; 2021 Feb; 236(2):1158-1183. PubMed ID: 32710499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma.
    Chen SH; Xu LY; Wu YP; Ke ZB; Huang P; Lin F; Li XD; Xue XY; Wei Y; Zheng QS; Xu N
    BMC Cancer; 2021 Jan; 21(1):79. PubMed ID: 33468079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of marker genes and cell subtypes in castration-resistant prostate cancer cells.
    Lin XD; Lin N; Lin TT; Wu YP; Huang P; Ke ZB; Lin YZ; Chen SH; Zheng QS; Wei Y; Xue XY; Lin RJ; Xu N
    J Cancer; 2021; 12(4):1249-1257. PubMed ID: 33442423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Potential Mechanism of Temozolomide Resistance in Glioma-Ferroptosis.
    Hu Z; Mi Y; Qian H; Guo N; Yan A; Zhang Y; Gao X
    Front Oncol; 2020; 10():897. PubMed ID: 32656078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinesin family member 18B regulates the proliferation and invasion of human prostate cancer cells.
    Wu YP; Ke ZB; Zheng WC; Chen YH; Zhu JM; Lin F; Li XD; Chen SH; Cai H; Zheng QS; Wei Y; Xue XY; Xu N
    Cell Death Dis; 2021 Mar; 12(4):302. PubMed ID: 33753726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 18F-FDG-PET/CT in Combination With Neutrophil-Lymphocyte Ratio in the Diagnosis of Upper Urinary Tract Lesion: Can We Accurately Predict Malignant Tumor?
    Ke ZB; Lin XD; Chen YH; Lin YZ; Chen SH; Chen SM; Chen Y; Wei Y; Zheng QS; Xue XY; Li XD; Xu N
    Front Oncol; 2021; 11():615881. PubMed ID: 34631509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
    Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
    Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.